title: Association of the histamine N-methyltransferase C314T (Thr105Ile) polymorphism with atopic dermatitis in Caucasian children.
abstract: OBJECTIVE
  To investigate potential associations between the histamine N-methyltransferase (HNMT) gene, HNMT, C314T (Thr105Ile) polymorphism and atopic dermatitis in a cohort of Caucasian children.
  
  
  METHODS
  Prospective, multicenter, genotype-association study.
  
  
  METHODS
  Four academic, tertiary care medical centers within the Pediatric Pharmacology Research Unit network.
  
  
  METHODS
  Two hundred forty-nine Caucasian children aged 6 months-5 years with atopic dermatitis (127 patients) or without (122 control subjects).
  
  
  METHODS
  Buccal swabs (one swab/cheek) were performed to obtain epithelial cells for extraction of genomic DNA.
  
  
  RESULTS
  Data were collected on severity of atopic dermatitis, oral antihistamine treatment, and treatment response through parental report. The HNMT genotypes were successfully obtained in 116 control subjects and 122 patients with atopic dermatitis. Frequencies of the T314 variant allele (0.12 vs 0.06, p=0.04) and combined CT/TT genotype (0.24 vs 0.12, p=0.02) were significantly higher in children with atopic dermatitis compared with control subjects. Children with genotypes conferring reduced HNMT activity were 2 times more likely to have atopic dermatitis than those who were homozygous for the C314 reference allele.
  
  
  CONCLUSIONS
  Increased histamine levels in patients with atopic dermatitis may result, at least in part, from reduced enzymatic inactivation via HNMT. Genetically associated reduction in histamine biotransformation may therefore contribute to the pathogenesis, persistence, and progression of atopic dermatitis. If confirmed, these data indicate that HNMT genotype might represent a common risk factor for development of atopic dermatitis, asthma, and allergic rhinitis and may be useful in identifying individuals who are candidates for early preventive pharmacotherapeutic intervention. Additional longitudinal studies will be required to assess the relationship between genotype, disease severity, and antihistamine response.
authors.affiliation: Kosair Charities Pediatric Clinical Research Unit, Department of Pediatrics, School of Medicine, University of Louisville, Louisville, KY 40202, USA. mjkenn07@louisville.edu
authors.forename: Mary Jayne
authors.initials: MJ
authors.lastname: Kennedy
authors.forename: Jennifer A
authors.initials: JA
authors.lastname: Loehle
authors.forename: Angela R
authors.initials: AR
authors.lastname: Griffin
authors.forename: Mark A
authors.initials: MA
authors.lastname: Doll
authors.forename: Gregory L
authors.initials: GL
authors.lastname: Kearns
authors.forename: Janice E
authors.initials: JE
authors.lastname: Sullivan
authors.forename: David W
authors.initials: DW
authors.lastname: Hein
mesh_terms: D000483:Alleles; D002675:Child, Preschool; D003876:Dermatitis, Atopic / Q000188:drug therapy / Q000208:ethnology / Q000235:genetics*; D005260:Female; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006633:Histamine Antagonists / Q000627:therapeutic use; D006637:Histamine N-Methyltransferase / Q000235:genetics*; D006801:Humans; D007223:Infant; D008297:Male; D009061:Mouth Mucosa / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D020641:Polymorphism, Single Nucleotide; D011446:Prospective Studies; D016896:Treatment Outcome; D044465:White People / Q000235:genetics*
chemical_list: D006633:Histamine Antagonists; D006637:Histamine N-Methyltransferase